Preferential Colonization of Metastases by Oncolytic Vaccinia Virus Strain GLV-1h68 in a Human PC-3 Prostate Cancer Model in Nude Mice

Preferential Colonization of Metastases by Oncolytic Vaccinia Virus Strain GLV-1h68 in a Human PC-3 Prostate Cancer Model in Nude Mice

Recently, we showed that the oncolytic vaccinia virus GLV-1h68 has a significant therapeutic potential in treating lymph node metastases of human PC-3 prostate carcinoma in tumor xenografts. In this study, underlying mechanisms of the virus-mediated metastases reduction were analyzed. Immunohistoche...

Full description

Bibliographic Details
Main Authors:	Donat, Ulrike, Weibel, Stephanie, Hess, Michael, Stritzker, Jochen, Härtl, Barbara, Sturm, Julia B., Chen, Nanhai G., Gentschev, Ivaylo, Szalay, Aladar A.
Format:	Online
Language:	English
Published:	Public Library of Science 2012
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3457966/

Similar Items

Virotherapy of Canine Tumors with Oncolytic Vaccinia Virus GLV-1h109 Expressing an Anti-VEGF Single-Chain Antibody
by: Patil, Sandeep S., et al.
Published: (2012)

Efficient Colonization and Therapy of Human Hepatocellular Carcinoma (HCC) Using the Oncolytic Vaccinia Virus Strain GLV-1h68
by: Gentschev, Ivaylo, et al.
Published: (2011)

Growth inhibition of different human colorectal cancer xenografts after a single intravenous injection of oncolytic vaccinia virus GLV-1h68
by: Ehrig, Klaas, et al.
Published: (2013)

Evaluation of a New Recombinant Oncolytic Vaccinia Virus Strain GLV-5b451 for Feline Mammary Carcinoma Therapy
by: Adelfinger, Marion, et al.
Published: (2014)

Bacterial glucuronidase as general marker for oncolytic virotherapy or other biological therapies
by: Hess, Michael, et al.
Published: (2011)

Preclinical Testing Oncolytic Vaccinia Virus Strain GLV-5b451 Expressing an Anti-VEGF Single-Chain Antibody for Canine Cancer Therapy
by: Adelfinger, Marion, et al.
Published: (2015)

Permissivity of the NCI-60 cancer cell lines to oncolytic Vaccinia Virus GLV-1h68
by: Ascierto, Maria Libera, et al.
Published: (2011)

Preclinical Evaluation of Oncolytic Vaccinia Virus for Therapy of Canine Soft Tissue Sarcoma
by: Gentschev, Ivaylo, et al.
Published: (2012)

Oncolytic vaccinia virus GLV-1h68 strain shows enhanced replication in human breast cancer stem-like cells in comparison to breast cancer cells
by: Wang, Huiqiang, et al.
Published: (2012)

Targeting hematologic malignancies with oncolytic vaccinia virus constructs
by: Chen, Nanhai, et al.
Published: (2013)

Microglia and astrocytes attenuate the replication of the oncolytic vaccinia virus LIVP 1.1.1 in murine GL261 gliomas by acting as vaccinia virus traps
by: Kober, Christina, et al.
Published: (2015)

Combination treatment with oncolytic Vaccinia virus and cyclophosphamide results in synergistic antitumor effects in human lung adenocarcinoma bearing mice
by: Hofmann, Elisabeth, et al.
Published: (2014)

Vaccinia virus-mediated intra-tumoral expression of matrix metalloproteinase 9 enhances oncolysis of PC-3 xenograft tumors
by: Schäfer, Simon, et al.
Published: (2012)

Functional hyper-IL-6 from vaccinia virus-colonized tumors triggers platelet formation and helps to alleviate toxicity of mitomycin C enhanced virus therapy
by: Sturm, Julia B, et al.
Published: (2012)

Oncolytic Virotherapy of Canine and Feline Cancer
by: Gentschev, Ivaylo, et al.
Published: (2014)

Replication efficiency of oncolytic vaccinia virus in cell cultures prognosticates the virulence and antitumor efficacy in mice
by: Chen, Nanhai G, et al.
Published: (2011)

Oncolytic virotherapy in veterinary medicine: current status and future prospects for canine patients
by: Patil, Sandeep S, et al.
Published: (2012)

Treatment of malignant effusion by oncolytic virotherapy in an experimental subcutaneous xenograft model of lung cancer
by: Weibel, Stephanie, et al.
Published: (2013)

Oncolytic Viruses
by: Chen, Nanhai G., et al.
Published: (2012)

Vaccinia virus GLV-1h153 is a novel agent for detection and effective local control of positive surgical margins for breast cancer
by: Gholami, Sepideh, et al.
Published: (2013)

Intratumoral INF-γ triggers an antiviral state in GL261 tumor cells: a major hurdle to overcome for oncolytic vaccinia virus therapy of cancer
by: Kober, Christina, et al.
Published: (2015)

Characterization of Metastasis Formation and Virotherapy in the Human C33A Cervical Cancer Model
by: Donat, Ulrike, et al.
Published: (2014)

Molecular network, pathway, and functional analysis of time-dependent gene changes associated with pancreatic cancer susceptibility to oncolytic vaccinia virotherapy
by: Haddad, Dana, et al.
Published: (2016)

Imaging of Intratumoral Inflammation during Oncolytic Virotherapy of Tumors by 19F-Magnetic Resonance Imaging (MRI)
by: Weibel, Stephanie, et al.
Published: (2013)

Colonization of xenograft tumors by oncolytic vaccinia virus (VACV) results in enhanced tumor killing due to the involvement of myeloid cells
by: Kilinc, Mehmet Okyay, et al.
Published: (2016)

Imaging Characteristics, Tissue Distribution, and Spread of a Novel Oncolytic Vaccinia Virus Carrying the Human Sodium Iodide Symporter
by: Haddad, Dana, et al.
Published: (2012)

Combination immunotherapy with oncolytic vaccinia virus and checkpoint inhibitor following local tumor irradiation
by: Minev, Boris, et al.
Published: (2014)

Expression of anti-VEGF antibody together with anti-EGFR or anti-FAP enhances tumor regression as a result of vaccinia virotherapy
by: Huang, Ting, et al.
Published: (2015)

Theranostic Potential of Oncolytic Vaccinia Virus
by: Rojas, Juan J, et al.
Published: (2012)

Immunotherapeutic Potential of Oncolytic Vaccinia Virus
by: Thorne, Steve H.
Published: (2014)

Insertion of the human sodium iodide symporter to facilitate deep tissue imaging does not alter oncolytic or replication capability of a novel vaccinia virus
by: Haddad, Dana, et al.
Published: (2011)

A novel oncolytic viral therapy and imaging technique for gastric cancer using a genetically engineered vaccinia virus carrying the human sodium iodide symporter
by: Jun, Kyong-Hwa, et al.
Published: (2014)

Doxycycline Inducible Melanogenic Vaccinia Virus as Theranostic Anti-Cancer Agent
by: Kirscher, Lorenz, et al.
Published: (2015)

Vaccinia virus expressing bone morphogenetic protein-4 in novel glioblastoma orthotopic models facilitates enhanced tumor regression and long-term survival
by: Duggal, Rohit, et al.
Published: (2013)

Optical Detection and Virotherapy of Live Metastatic Tumor Cells in Body Fluids with Vaccinia Strains
by: Wang, Huiqiang, et al.
Published: (2013)

Effect of aldosterone on the amplification of oncolytic vaccinia virus in human cancer lines
by: Lee, Hyun Ju, et al.
Published: (2011)

Polymeric Cups for Cavitation-mediated Delivery of Oncolytic Vaccinia Virus
by: Myers, Rachel, et al.
Published: (2016)

Apoptin enhances the oncolytic properties of vaccinia virus and modifies mechanisms of tumor regression
by: Kochneva, Galina, et al.
Published: (2014)

The Addition of Recombinant Vaccinia HER2/neu to Oncolytic Vaccinia-GMCSF Given into the Tumor Microenvironment Overcomes MDSC-Mediated Immune Escape and Systemic Anergy
by: de Vries, Christiaan R., et al.
Published: (2015)

Interferon gamma is involved in the recovery of athymic nude mice from recombinant vaccinia virus/interleukin 2 infection
Published: (1990)